Portfolio (Quarterly)
Guide ↗
SILVERARC CAPITAL MANAGEMENT, LLC
· CIK 0001816307| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | PCVX | VAXCYTE INC | Healthcare | 314,339.0 | $11.3M | 1.53% | NEW | — | $36.02 | +36.0% |
| 22 | BIIB | BIOGEN INC | Healthcare | 80,419.0 | $11.3M | 1.52% | NEW | — | $140.08 | +37.5% |
| 23 | — | ASCENDIS PHARMA A/S | — | 53,554.0 | $10.6M | 1.44% | NEW | — | $198.81 | — |
| 24 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 2,833,988.0 | $9.9M | 1.34% | NEW | — | $3.50 | -47.3% |
| 25 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 700,000.0 | $9.5M | 1.28% | NEW | — | $13.59 | -5.0% |
| 26 | — | VERASTEM INC | — | 1,042,757.0 | $9.2M | 1.24% | NEW | — | $8.83 | — |
| 27 | — | AVALO THERAPEUTICS INC | — | 720,922.0 | $9.2M | 1.24% | NEW | — | $12.71 | — |
| 28 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 933,541.0 | $9.1M | 1.23% | NEW | — | $9.79 | +36.2% |
| 29 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 348,922.0 | $9.0M | 1.22% | NEW | — | $25.87 | +15.6% |
| 30 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 233,920.0 | $8.7M | 1.18% | NEW | — | $37.24 | +27.2% |
| 31 | VCYT | VERACYTE INC | Healthcare | 235,791.0 | $8.1M | 1.09% | NEW | — | $34.33 | +20.2% |
| 32 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 463,708.0 | $7.1M | 0.96% | NEW | — | $15.39 | +27.4% |
| 33 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 203,946.0 | $6.1M | 0.82% | NEW | — | $29.70 | +19.0% |
| 34 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 259,509.0 | $5.6M | 0.76% | NEW | — | $21.58 | -26.0% |
| 35 | ALKS | ALKERMES PLC | Healthcare | 180,513.0 | $5.4M | 0.73% | NEW | — | $30.00 | +24.8% |
| 36 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 588,789.0 | $5.4M | 0.73% | NEW | — | $9.15 | +47.3% |
| 37 | — | BRIDGEBIO ONCOLOGY THERAPEUT | — | 457,414.0 | $5.3M | 0.71% | NEW | — | $11.58 | — |
| 38 | — | ABEONA THERAPEUTICS INC | — | 994,754.0 | $5.3M | 0.71% | NEW | — | $5.28 | — |
| 39 | LXEO | LEXEO THERAPEUTICS INC | Healthcare | 778,611.0 | $5.2M | 0.70% | NEW | — | $6.64 | -27.8% |
| 40 | — CALL | COGENT BIOSCIENCES INC | — | 360,000.0 | $5.2M | 0.70% | NEW | — | $14.36 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%